LAS VEGAS–(BUSINESS WIRE)–Quectel Wireless Solutions, an end-to-end global IoT solutions provider, today announces the launch of a new-generation smart robotic LAS VEGAS–(BUSINESS WIRE)–Quectel Wireless Solutions, an end-to-end global IoT solutions provider, today announces the launch of a new-generation smart robotic

Quectel Introduces SH602HA-AP Smart Robotic Computing Module to Power Next Generation of Robotic Devices

LAS VEGAS–(BUSINESS WIRE)–Quectel Wireless Solutions, an end-to-end global IoT solutions provider, today announces the launch of a new-generation smart robotic computing module, the SH602HA-AP. Based on the D-Robotics Sunrise 5 (X5M) chip platform and with an integrated Ubuntu operating system, the module features up to 10 TOPs of brain processing units (BPU) computing power.

Designed for demanding robotic workloads, this high-performance module enables end-to-end computing, supports advanced large-scale models such as Transformer, Bird’s-Eye View (BEV), and Occupancy, and efficiently executes full-stack processing tasks with high performance and reliability.

The module offers exceptional flexibility, working seamlessly with Quectel’s independent LTE Cat 1, LTE Cat 4, 5G, Wi-Fi 6, and GNSS modules to expand connectivity options and enable a broader range of robotics use cases. These include smart displays, express lockers, electricity equipment, industrial control terminals and smart home appliances.

“This module supports edge compute and vision functions among others in robotic applications as the industry adopts robot perception to power the next generation of use cases,” said James Jia, Product Head, Quectel Wireless Solution. “This smart module’s ability to efficiently execute on full-stack computing tasks for robots takes us into a new era and Quectel is proud to be helping customers build a smarter world.”

Data input and fusion processing for multiple sensors, including Lidar, structured light, time of flight (TOF) and voice are enabled by the Quectel SH602HA-AP fully meeting the requirements for AI and vision functions in robotic applications. With dimensions of 40.5mm x 40.5mm x 2.9mm, the module operates in the -25 °C to +85 °C temperature range with default memory of 4GB plus 32GB and numerous memory options.

The module supports 4k video at 60fps with video encoding and decoding, binocular depth processing, AI and visual simultaneous localization and mapping (VSLAM), speech recognition, 3D point cloud computing and other mainstream robot perception algorithms. The Quectel SH602HA-AP offers Bluetooth, DSI, RGMII, USB 3.0, USB 2.0, SDIO, QSPI, seven UART, seven I2C and two I2S interfaces

The module integrates easily with additional Quectel modules, such as the KG200Z LoRa and the FCS950 Wi-Fi and Bluetooth module, enabling flexible connectivity options.

About Quectel

Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are an end-to-end global IoT solutions provider backed by outstanding support and services.

With a worldwide team of over 5,800 professionals, we lead the way in delivering end-to-end IoT solutions, spanning cellular, GNSS, satellite, Wi-Fi and Bluetooth modules, high-performance antennas, value-added services and full turnkey offerings including ODM services and system integration.

With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.

For more information, please visit: www.quectel.com or LinkedIn

Contacts

Media contact: media@quectel.com

Market Opportunity
Smart Blockchain Logo
Smart Blockchain Price(SMART)
$0.005075
$0.005075$0.005075
+1.23%
USD
Smart Blockchain (SMART) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26